Status:
RECRUITING
Persistence of Immune Response Six Years After One Dose of 9vHPV Vaccine Among Male and Female Students
Lead Sponsor:
Canadian Immunization Research Network
Conditions:
HPV Vaccine
Eligibility:
All Genders
15-17 years
Phase:
PHASE4
Brief Summary
Since the 2019-2020 school year, the province of Quebec (Canada) has been administering one dose of nonavalent (9vHPV) vaccine to students of all genders in Grade 4 of elementary school through the sc...
Detailed Description
Since the 2019-2020 school year, the province of Quebec (Canada) has been administering one dose of nonavalent (9vHPV) vaccine to students of all genders in Grade 4 of elementary school through the sc...
Eligibility Criteria
Inclusion
- Have received a single dose of 9vHPV vaccine at ages 9-11 during the school year 2019-2020;
- Not have received any other HPV vaccine doses;
- Be able to consent to the study.
Exclusion
- Immunosuppressed (at recruitment or when immunized).
Key Trial Info
Start Date :
September 23 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2026
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT07156084
Start Date
September 23 2025
End Date
February 1 2026
Last Update
September 29 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre de recherche du CHU de Québec-Université Laval
Québec, Quebec, Canada, G1X4S9